How to Source Imipenem + Cilastatin IV for Pharmaceutical Formulation

Imipenem + Cilastatin IV (Intravenous (IV) Solutions, 500 mg/500 mg, 1 g/1 g per vial) is classified under Antibiotics. It is therapeutically aligned with reference brands such as Primaxin, Gemax (US & EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Imipenem + Cilastatin IV for formulation, R&D, or bulk manufacturing.

Imipenem + Cilastatin IV API in Intravenous (IV) Solutions form, 500 mg/500 mg, 1 g/1 g per vial specification
Imipenem + Cilastatin IV API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Imipenem + Cilastatin IV must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Imipenem + Cilastatin IV is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Imipenem + Cilastatin IV is more than procurement—it’s a strategic partnership. With its intravenous (iv) solutions form and 500 mg/500 mg, 1 g/1 g per vial specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Imipenem + Cilastatin IV. Request a Quote

Frequently Asked Questions For Sourcing of Imipenem + Cilastatin IV

What is the typical lead time for Imipenem + Cilastatin IV?

Lead times range from 4–6 weeks depending on supplier and region.

Is Imipenem + Cilastatin IV available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Imipenem + Cilastatin IV require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Imipenem + Cilastatin IV?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Imipenem + Cilastatin IV?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Imipenem + Cilastatin IV?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Imipenem + Cilastatin IV suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Imipenem + Cilastatin IV be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.